Age Moderates the Effect of Obesity on Mortality Risk in Critically Ill Patients With COVID-19: A Nationwide Observational Cohort Study.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
01 04 2023
Historique:
pubmed: 11 2 2023
medline: 22 3 2023
entrez: 10 2 2023
Statut: ppublish

Résumé

A high body mass index (BMI) is associated with an unfavorable disease course in COVID-19, but not among those who require admission to the ICU. This has not been examined across different age groups. We examined whether age modifies the association between BMI and mortality among critically ill COVID-19 patients. An observational cohort study. A nationwide registry analysis of critically ill patients with COVID-19 registered in the National Intensive Care Evaluation registry. We included 15,701 critically ill patients with COVID-19 (10,768 males [68.6%] with median [interquartile range] age 64 yr [55-71 yr]), of whom 1,402 (8.9%) patients were less than 45 years. None. In the total sample and after adjustment for age, gender, Acute Physiology and Chronic Health Evaluation IV, mechanical ventilation, and use of vasoactive drugs, we found that a BMI greater than or equal to 30 kg/m 2 does not affect hospital mortality (adjusted odds ratio [OR adj ] = 0.98; 95% CI, 0.90-1.06; p = 0.62). For patients less than 45 years old, but not for those greater than or equal to 45 years old, a BMI greater than or equal to 30 kg/m 2 was associated with a lower hospital mortality (OR adj = 0.59; 95% CI, 0.36-0.96; p = 0.03). A higher BMI may be favorably associated with a lower mortality among those less than 45 years old. This is in line with the so-called "obesity paradox" that was established for other groups of critically ill patients in broad age ranges. Further research is needed to understand this favorable association in young critically ill patients with COVID-19.

Identifiants

pubmed: 36762902
doi: 10.1097/CCM.0000000000005788
pii: 00003246-202304000-00005
pmc: PMC10012838
doi:

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

484-491

Investigateurs

M S Arbous (MS)
M G W Barnas (MGW)
D P Boer (DP)
R J Bosman (RJ)
G B Brunnekreef (GB)
M Th de Bruin (MT)
M J de Graaff (MJ)
R M de Jong (RM)
A R de Meijer (AR)
W de Ruijter (W)
R de Waal (R)
A Dijkhuizen (A)
D A Dongelmans (DA)
T P J Dormans (TPJ)
A Draisma (A)
I Drogt (I)
B J W Eikemans (BJW)
P W G Elbers (PWG)
J L Epker (JL)
M L Erkamp (ML)
B Festen-Spanjer (B)
T Frenzel (T)
L Georgieva (L)
N C Gritters (NC)
I Z Hené (IZ)
M Hoeksema (M)
J W M Holtkamp (JWM)
M E Hoogendoorn (ME)
C J G M Jacobs (CJGM)
I T A Janssen (ITA)
H Kieft (H)
M P Koetsier (MP)
T J J Koning (TJJ)
H Kreeftenberg (H)
N Kusadasi (N)
J A Lens (JA)
J G Lutisan (JG)
D J Mehagnoul-Schipper (DJ)
D Moolenaar (D)
F Nooteboom (F)
N Postma (N)
R V Pruijsten (RV)
D Ramnarain (D)
A C Reidinga (AC)
E Rengers (E)
A A Rijkeboer (AA)
T Rijpstra (T)
F W Rozendaal (FW)
R M Schnabel (RM)
V M Silderhuis (VM)
J J Spijkstra (JJ)
P E Spronk (PE)
L F Te Velde (LF)
L C Urlings-Strop (LC)
A E van den Berg (AE)
R van den Berg (R)
I C C van der Horst (ICC)
E M van Driel (EM)
L van Gulik (L)
F M van Iersel (FM)
M van Lieshout (M)
J A H van Oers (JAH)
E R van Slobbe-Bijlsma (ER)
M van Tellingen (M)
J Vandeputte (J)
D P Verbiest (DP)
D J Versluis (DJ)
E Verweij (E)
M Vrolijk-de Mos (M)
R M J Wesselink (RMJ)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

Dr. Rietdijk, Sablerolles, and van der Kuy received funding for conducting COVID-19 research from the Leading Online Entrepreneur of the Year (LOEY) foundation. Drs. Termorshuizen’s and de Keizer’s institutions received funding from the National Intensive Care Evaluation (NICE) Foundation. Dr. Termorshuizen received funding from the Mental Health Care Institute Rivierduinen. Dr. de Keizer’s institution received funding from The Netherlands Organisation for Health Research and Development (ZonMw) COVID-19 Programme; she disclosed that she is a NICE board member. Although, the LOEY foundation and ZonMw provided a grant to conduct COVID-19 research, they were not involved in the design, execution, and/or publication of this study. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Références

Gao M, Piernas C, Astbury NM, et al.: Associations between body-mass index and COVID-19 severity in 6.9 million people in England: A prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021; 9:350–359
Kooistra EJ, Brinkman S, van der Voort PHJ, et al.: Body mass index and mortality in coronavirus disease 2019 and other diseases: A cohort study in 35,506 ICU patients. Crit Care Med. 2022; 50:e1–e10
Dana R, Bannay A, Bourst P, et al.: Obesity and mortality in critically ill COVID-19 patients with respiratory failure. Int J Obes. 2021; 1:10
Network C-IGobotR, the C-ICUI: Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: A prospective cohort study. Intensive Care Med. 2021; 47:60–73
Kass DA, Duggal P, Cingolani O: Obesity could shift severe COVID-19 disease to younger ages. Lancet. 2020; 395:1544–1545
Bhasin A, Nam H, Yeh C, et al.: Is BMI higher in younger patients with COVID-19? Association between BMI and COVID-19 hospitalization by age. Obesity. 2020; 28:1811–1814
Liu Y, Mao B, Liang S, et al.: Association between age and clinical characteristics and outcomes of COVID-19. Eur Respir J. 2020; 55:2001112
Groenland CNL, Termorshuizen F, Rietdijk WJR, et al.: Emergency department to ICU time is associated with hospital mortality: A registry analysis of 14,788 patients from six university hospitals in The Netherlands. Crit Care Med. 2019; 47:1564–1571
Todorov A, Kaufmann F, Arslani K, et al.: Gender differences in the provision of intensive care: A Bayesian approach. Intensive Care Med. 2021; 47:577–587
De Jong A, Wrigge H, Hedenstierna G, et al.: How to ventilate obese patients in the ICU. Intensive Care Med. 2020; 1:13
Decruyenaere A, Steen J, Colpaert K, et al.: The obesity paradox in critically ill patients: A causal learning approach to a casual finding. Crit Care. 2020; 24:485
Ades PA, Savage PD: The obesity paradox: Perception vs knowledge. Mayo Clin Proc. 2010; 85:112–114
Consortium C-CC, Group LS: Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: A cohort study across 18 countries. Eur Heart J. 2022; 43:1104–1120
Banack HR, Stokes A: The “obesity paradox” may not be a paradox at all. Int J Obes (Lond). 2017; 41:1162–1163
Sperrin M, Candlish J, Badrick E, et al.: Collider bias is only a partial explanation for the obesity paradox. Epidemiology. 2016; 27:525–530
Emerson P, Brooks D, Quasim T, et al.: Factors influencing intensive care admission: A mixed methods study of EM and ICU. Eur J Emerg Med. 2017; 24:29–35
Banack HR, Kaufman JS: Does selection bias explain the obesity paradox among individuals with cardiovascular disease? Ann Epidemiol. 2015; 25:342–349
Henkens M, Raafs AG, Verdonschot JAJ, et al.: Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study. BMC Geriatr. 2022; 22:184
Harwood R, Yan H, Talawila Da Camara N, et al.: Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis. EClinicalMedicine. 2022; 44:101287
Contou D, Cally R, Sarfati F, et al.: Causes and timing of death in critically ill COVID-19 patients. Crit Care. 2021; 25:79
Toft-Petersen AP, Wulff J, Harrison DA, et al.: Exploring the impact of using measured or estimated values for height and weight on the relationship between BMI and acute hospital mortality. J Crit Care. 2018; 44:196–202

Auteurs

Corstiaan A den Uil (CA)

Department of Intensive Care, Maasstad Hospital, Rotterdam, The Netherlands.
Department of Intensive Care, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Department of Cardiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
National Intensive Care Evaluation (NICE) Foundation, Amsterdam, The Netherlands.
Department of Medical Informatics, Amsterdam UMC, Amsterdam Public Health research institute, University of Amsterdam, Amsterdam, The Netherlands.
Department of Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Department of Intensive Care, Diakonessenhuis, Utrecht, The Netherlands.
Department of Intensive Care, University Medical Center Groningen, Groningen, The Netherlands.
Department of Intensive Care, Dutch Poisons Information Center (DPIC), University Medical Center, Utrecht University, Utrecht, The Netherlands.
Department of Intensive Care, Radboud University Medical Center, Nijmegen, The Netherlands.

Fabian Termorshuizen (F)

National Intensive Care Evaluation (NICE) Foundation, Amsterdam, The Netherlands.
Department of Medical Informatics, Amsterdam UMC, Amsterdam Public Health research institute, University of Amsterdam, Amsterdam, The Netherlands.

Wim J R Rietdijk (WJR)

Department of Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

Roos S G Sablerolles (RSG)

Department of Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

Hugo P M van der Kuy (HPM)

Department of Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

Lenneke E M Haas (LEM)

Department of Intensive Care, Diakonessenhuis, Utrecht, The Netherlands.

Peter H J van der Voort (PHJ)

Department of Intensive Care, University Medical Center Groningen, Groningen, The Netherlands.

Dylan W de Lange (DW)

Department of Intensive Care, Dutch Poisons Information Center (DPIC), University Medical Center, Utrecht University, Utrecht, The Netherlands.

Peter Pickkers (P)

Department of Intensive Care, Radboud University Medical Center, Nijmegen, The Netherlands.

Nicolette F de Keizer (NF)

National Intensive Care Evaluation (NICE) Foundation, Amsterdam, The Netherlands.
Department of Medical Informatics, Amsterdam UMC, Amsterdam Public Health research institute, University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH